Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Radiotherapy is the dominant treatment modality for painful spine and non-spine bone metastases (NSBM). Historically, this was achieved with conventional low dose external beam radiotherapy, however, stereotactic body radiotherapy (SBRT) is increasingly applied for these indications. Meta-analyses and randomized clinical trials have demonstrated improved pain response and more durable tumor control with SBRT for spine metastases. However, in the setting of NSBM, there is limited evidence supporting global adoption and large scale randomized clinical trials are in need. SBRT is technically demanding requiring careful consideration of organ at risk tolerance, and strict adherence to technical requirements including immobilization, simulation, contouring and image-guidance procedures. Additional considerations include follow up practices after SBRT, with appropriate imaging playing a critical role in response assessment. Finally, there is renewed research into promising new technologies that may further refine the use of SBRT in both spinal and NSBM in the years to come. © 2023 The Authors.

Citation

Laura Burgess, Eric Nguyen, Chia-Lin Tseng, Matthias Guckenberger, Simon S Lo, Beibei Zhang, Michelle Nielsen, Pejman Maralani, Quynh-Nhu Nguyen, Arjun Sahgal. Practice and principles of stereotactic body radiation therapy for spine and non-spine bone metastases. Clinical and translational radiation oncology. 2024 Mar;45:100716


PMID: 38226025

View Full Text